Age: 29
Free Agency: 2029 (UFA)
Accrued Seasons: 7
- Height: 6'3"
- Weight: 286
- College: Ohio State
- Entry: 2019 Draft, Round 3, #71 overall (Broncos)
- 2026 Salary Cap Charge: $7,546,666 (2.14% of cap)
- 2026 Cash Payout: $14,500,000 (4.56% of spending)
- 2026 Cash to Cap Ratio: 1.92
- Contract Value: $36,500,000 ($12,166,667 APY)
- Fully Guaranteed Money: $23,280,000
- Contract Ranking: 28/292 at IDL
Current Contract
(UFA, signed 2026)
(📝: indicates contract trigger occuring during that year)| Year | Age | Base Salary | Prorated Signing Bonus | Per Game Roster Bonus | Workout Bonus | Other Bonus | Guaranteed Salary | Cap Number | Cap % | Dead Money & Cap Savings | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 29 | $2,300,000 | $3,726,666 | $1,020,000 | $180,000 | $500,000 | $2,300,000 | $7,546,666 | 2.1% | |||||
| 2027 | 30 | $9,800,000 | $3,726,666 | $1,020,000 | $180,000 | $0 | $9,800,000 | $14,726,666 | 4.5% | |||||
| 2028 | 31 | $9,800,000 | $3,726,668 | $1,020,000 | $180,000 | $0 | $0 | $14,726,668 | 4.2% | |||||
| Total | $21,900,000 | $11,180,000 | $3,060,000 | $540,000 | $500,000 | $12,100,000 | $37,000,000 | |||||||
Contract Notes
Dre'Mont Jones signed a three-year contract with the New England Patriots worth $36.5 million base value with $23.1 million guaranteed including a $11 million signing bonus. Jones has full guaranteed salaries in 2026 and 2027, and can earn up to $3 million in playtime incentives.
Cash Flows
| 2026 | 2027 | 2028 | |
|---|---|---|---|
| Cash Due | $14,500,000 | $11,000,000 | $11,000,000 |
| Running Cash | $14,500,000 | $25,500,000 | $36,500,000 |
Career Earnings: $60,282,600
Career APY: $8,611,800
Contract History
| Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
|---|---|---|---|---|---|---|---|---|---|---|
| Broncos | Drafted | Expired | 2019 | 4 | $4,158,800 | $1,039,700 | $1,066,400 | $5,662,600 | 136.2% | $1,415,650 |
| Seahawks | UFA | Terminated | 2023 | 3 | $51,530,000 | $17,176,667 | $23,000,000 | $35,020,000 | 68.0% | $17,510,000 |
| Ravens | SFA | Expired | 2025 | 1 | $8,500,000 | $8,500,000 | $7,900,000 | $1,335,000 | 15.7% | $1,335,000 |
| Titans | SFA | Traded | 2025 | 1 | $8,500,000 | $8,500,000 | $7,990,000 | $0 | 0.0% | $0 |
| Patriots | UFA | Active | 2026 | 3 | $36,500,000 | $12,166,667 | $23,280,000 | $11,000,000 | 30.1% | $0 |
Earnings By Team
| Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
|---|---|---|---|---|---|---|---|
| Broncos | 4 | $5,662,600 | $1,415,650 | $5,662,600 | 0.0% | $0 | 0.0% |
| Seahawks | 2 | $35,020,000 | $17,510,000 | $20,947,082 | 0.0% | $14,072,918 | 0.0% |
| Ravens | 1 | $1,335,000 | $1,335,000 | $1,235,000 | 0.0% | $0 | 0.0% |
| Titans | 0 | $7,265,000 | $0 | $0 | 0.0% | $7,265,000 | 0.0% |
| Patriots | 0 | $11,000,000 | $0 | $0 | 0.0% | $0 | 0.0% |
Season History
| Year | Team | Base Salary | Prorated Bonus | Per Game Roster Bonus | Workout Bonus | Other Bonus | Guaranteed Salary | Cap Number | Cap % | Cash Paid | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | Broncos | $495,000 | $266,600 | $0 | $0 | $0 | $0 | $761,600 | 0.4% | $1,561,400 | ||
| 2020 | Broncos | $685,400 | $266,600 | $0 | $0 | $0 | $0 | $952,000 | 0.4% | $685,400 | ||
| 2021 | Broncos | $875,800 | $266,600 | $0 | $0 | $0 | $0 | $1,142,400 | 0.6% | $875,800 | ||
| 2022 | Broncos | $2,540,000 | $266,600 | $0 | $0 | $0 | $0 | $2,806,600 | 1.3% | $2,540,000 | ||
| 2023 | Seahawks | $3,000,000 | $6,666,666 | $510,000 | $0 | $0 | $3,000,000 | $10,176,666 | 4.6% | $23,510,000 | ||
| 2024 | Seahawks | $1,125,000 | $9,135,416 | $510,000 | $0 | $0 | $0 | $10,770,416 | 4.1% | $11,510,000 | ||
| 2025 | Ravens | $1,990,000 | $0 | $510,000 | $0 | $0 | $995,000 | $1,235,000 | 0.4% | $1,335,000 | ||
| 2026 | Patriots | $2,300,000 | $3,726,666 | $1,020,000 | $180,000 | $500,000 | $2,300,000 | $7,546,666 | 2.1% | $14,500,000 | ||
| 2027 | Patriots | $9,800,000 | $3,726,666 | $1,020,000 | $180,000 | $0 | $9,800,000 | $14,726,666 | 4.5% | $11,000,000 | ||
| 2028 | Patriots | $9,800,000 | $3,726,668 | $1,020,000 | $180,000 | $0 | $0 | $14,726,668 | 4.2% | $11,000,000 | ||
| Total | $32,611,200 | $28,048,482 | $4,590,000 | $540,000 | $500,000 | $16,095,000 | $64,844,682 | $78,517,600 | ||||
Statistics
| Year | Games Played | Games Inactive | Snaps | Tackles | Negative Plays | Interceptions | Fumbles | TD | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Defense | Special | Solo | Assist | Sacks | Yards | TFL | QB Hits | Pass Def. | INT | Yards | Forced | Rec. | Yards | ||||
| 2019 | 14 | 2 | 27.0% | 25.5% | 8 | 6 | 3.5 | 22.5 | 3 | 6 | 2 | 1 | 7 | 0 | 0 | 0 | 0 |
| 2020 | 14 | 0 | 54.7% | 27.9% | 26 | 15 | 6.5 | 36 | 7 | 11 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 16 | 1 | 56.5% | 24.9% | 18 | 13 | 5.5 | 37.5 | 9 | 11 | 2 | 0 | 0 | 1 | 1 | 0 | 0 |
| 2022 | 13 | 2 | 57.8% | 12.4% | 24 | 23 | 6.5 | 47 | 9 | 10 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| 2023 | 17 | 0 | 64.1% | 17.1% | 26 | 23 | 4.5 | 23 | 5 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 18 | 0 | 57.7% | 13.4% | 14 | 14 | 4 | 35 | 7 | 13 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
| 2025 | 18 | 0 | 72.2% | 10.0% | 19 | 24 | 7 | 42 | 7 | 24 | 1 | 0 | 0 | 0 | 2 | 0 | 0 |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
| OTC Valuation | APY | |
|---|---|---|
| Regular | $15,233,000 | $12,166,667 |
| Injury Adjusted | $15,233,000 | $12,166,667 |
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.